Dexetimide
From Wikipedia, the free encyclopedia
Dexetimide
|
|
Systematic (IUPAC) name | |
3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione | |
Identifiers | |
CAS number | |
ATC code | N04 |
PubChem | |
Chemical data | |
Formula | C23H26N2O2 |
Mol. mass | 362.465 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Dexetimide is a piperidine anticholinergic. It is a muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.
[edit] References
- Dom R, Van Lommel R, Baro F., A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent, Acta Psychiatrica Scandinavica 1971;47(4):399-410.
- Huygens H, Vereecken JL, Tanghe A., Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action, Psychiatr Neurol Neurochir. 1973 Jul-Aug;76(4):251-9.
|